Related Articles
Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: Gene amplification does not contribute to EGFR expression
Lateral differences in Ki‑67 in breast cancer
Impact of chemotherapy on the expression of claudins and cadherins in invasive breast cancer
Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients
Mitochondrial DNA alterations correlate with the pathological status and the immunological ER, PR, HER-2/neu, p53 and Ki-67 expression in breast invasive ductal carcinoma